1 January 2007 in Acta Oto-Laryngologica
Conclusion. This study confirms the wide range of vascular architecture in juvenile angiofibromas. Proof of laminin α2 expression in tumour vessels is suggested to indicate presence of vessels of early developmental stage in juvenile angiofibromas, supporting the concept that plexus remnants of the first branchial arch artery contribute to the vascular tumour component. Objectives. Laminins, one of the major components of vascular wall basement membranes, have been implicated in tumour growth and have been shown to have developmentally regulated expression patterns. The goal of this study was to analyse the expression of laminins in juvenile angiofibromas. Materials and methods. A detailed analysis of the laminin isoform expression was performed by immunofluorescence staining for laminin chains α1, α2, α3, α4, α5, β1, β2, β3, γ1, γ2, and γ3 on cryosections of 10 juvenile angiofibromas and inferior nasal turbinate tissue for control. Results. Vascular staining of the different laminin chains revealed areas of differential vessel density in juvenile angiofibromas and irregularities in vessel size, configuration and architecture. Similar to vessels in nasal turbinates, laminins α4, α5, β1, β2 and γ1 were found to be expressed in juvenile angiofibroma vessels. In contrast to vessels of nasal turbinates, staining for α2 and α3 chains was only detected in vessels of juvenile angiofibromas.
1 January 2006 in Cancer Genetics and Cytogenetics
2 October 2004 in Cell and tissue research
5 February 2001 in Neuroradiology
1 January 2008 in Otology & Neurotology
Objective: To analyze temporal lobe gliosis and temporal lobe dysfunction after middle fossa vestibular schwannoma surgery. Study Design: Temporal lobe analysis of a series of cases. Setting: Tertiary referral center. Patients: Thirty-two patients after enlarged middle fossa surgery (EMFS) and 20 subjects for control (preferably husbands/wives). Interventions: Magnetic resonance evaluation of the temporal lobe and neuropsychological testing. Main Outcome Measures: Magnetic resonance imaging of the temporal lobe 1 year after treatment and neuropsychological testing (Berliner Amnesia Test [BAT], Boston Naming Test [BT], Token Test, Beck Depression Inventory, Freiburger Personality Inventory). Results: Temporal lobe gliosis after EMFS was observed in 22 of 32 analyzed patients (degree of gliosis: 11, slight; 9, moderate; 2, severe). Neuropsychological testing of 23 of the 32 previously analyzed patients after EMFS compared with control subjects (n = 20) found only in few subdomains (figural score, personality test) statistically significant worse test results, but no major disturbances of the temporal lobe function compared with the control group. Only one patient with a finding of severe temporal lobe gliosis was proven in the BAT and BT to have a temporal lobe deficit. Conclusion: In a significant number of patients, temporal lobe gliosis has to be expected after EMFS; however, the gliosis is only slight or moderate in most of the patients and not associated with essential functional deficits of the temporal lobe. Nevertheless, the possibility of a severe temporal lobe gliosis with functional deficits in the BAT and BT has to be taken into consideration.
22 November 2006 in Head & Neck